HHHeather Han

Heather Han

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Heather Han has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Jonathan P. Ling

    Departments of Pathology, Johns Hopkins Medicine, Baltimore, Maryland, USA

    1 shared publication
  • Juan C. Troncoso

    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA

    1 shared publication
  • Katherine D. LaClair

    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA

    1 shared publication
  • Liam Chen

    Neuropathology Division, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA

    1 shared publication
  • Mingkuan Sun

    The Key Laboratory of Modern Toxicology of Ministry of Education, Department of Toxicology, School of Public Health, Nanjing Medical University, Nanjing 211166, China

    1 shared publication
  • Olga Pletnikova

    Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, 21205, USA

    1 shared publication

Latest Publications

  • Cryptic exon incorporation occurs in Alzheimer’s brain lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43

    by Mingkuan Sun, William Bell, Katherine D. LaClair, Jonathan P. Ling, Heather Han, Yusuke Kageyama, Olga Pletnikova, Juan C. Troncoso, Philip C. Wong, Liam L. Chen

    Abnormal accumulation of TDP-43 into cytoplasmic or nuclear inclusions with accompanying nuclear clearance, a common pathology initially identified in amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), has also been found in Alzheimer’ disease (AD). TDP-43 serves as a splicing repressor of nonconserved cryptic exons and that such function is compromised in brains of ALS and FTD patients, suggesting that nuclear clearance of TDP-43 underlies its inability to repress cryptic exons. However, whether TDP-43 cytoplasmic aggregates are a prerequisite for the incorporation of cryptic exons is not known. Here, we assessed hippocampal tissues from 34 human postmortem brains including cases with confirmed diagnosis of AD neuropathologic changes along with age-matched controls. We found that cryptic exon incorporation occurred in all AD cases exhibiting TDP-43 pathology. Furthermore, incorporation of cryptic exons was observed in the hippocampus when TDP-43 inclusions was restricted only to the amygdala, the earliest stage of TDP-43 progression. Importantly, cryptic exon incorporation could be detected in AD brains lacking TDP-43 inclusion but exhibiting nuclear clearance of TDP-43. These data supports the notion that the functional consequence of nuclear depletion of TDP-43 as determined by cryptic exon incorporation likely occurs as an early event of TDP-43 proteinopathy and may have greater contribution to the pathogenesis of AD than currently appreciated. Early detection and effective repression of cryptic exons in AD patients may offer important diagnostic and therapeutic implications for this devastating illness of the elderly.